WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) reported a $59.1 million third-quarter profit, reversing a $7.7 million loss a year earlier, as proceeds from its patent settlement…

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) reported a $59.1 million third-quarter profit, reversing a $7.7 million loss a year earlier, as proceeds from its patent settlement with Moderna …

Source disclosure

This is a source-linked briefing. Read the original report from Mychesco .